PR-018
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PR-018, covering 2014-03-07 to 2014-03-07. Get the full timeline:
Most recent: Clinical Trial Update: PR-018: An Open-Label, Safety Extension of Study PR-011 [Phase 4]